Sanara MedTech Inc. (SMTI)
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Manufacturing · CIK 714256 · fiscal year ends in Dec
Closing price $32.84 on 30 Oct 2026; 52-week range $16.34 to $35.28.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $109.8M
- Revenue growth
- 12.9%
- Net income, last twelve months
- -$32.0M
- Earnings per share
- -$3.59
- Gross margin
- 93.0%
- Net margin
- -29.2%
- Free cash flow
- $4.5M
- Return on equity
- -403.0%
- Market value
- $301.9M
- Cash
- $15.4M
- Debt
- $46.5M
- Debt to equity
- 5.85
- Shares outstanding
- 9.2M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $103.1M | $7.3M | -$37.6M | -$4.36 | $2.2M | 10-K filed 24 Mar 2026 |
| FY2024 | 31 Dec 2024 | $86.7M | $1.3M | -$9.7M | -$1.14 | -$229.6K | 10-K filed 25 Mar 2025 |
| FY2023 | 31 Dec 2023 | $65.0M | -$4.2M | -$4.3M | -$0.52 | -$3.5M | 10-K filed 25 Mar 2024 |
| FY2022 | 31 Dec 2022 | $45.8M | -$12.5M | -$7.9M | -$1.00 | -$5.7M | 10-K filed 20 Mar 2023 |
| FY2021 | 31 Dec 2021 | $24.1M | -$7.4M | -$7.9M | -$1.08 | -$5.0M | 10-K filed 31 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $28.1M | -$452.9K | -$0.05 |
| Q1 FY2026 | 31 Mar 2026 | $27.8M | $459.0K | $0.05 |
| Q4 FY2025 | 31 Dec 2025 | $27.5M | -$1.6M | -$0.19 |
| Q3 FY2025 | 30 Sep 2025 | $26.3M | -$30.4M | -$3.40 |
| Q2 FY2025 | 30 Jun 2025 | $25.8M | -$2.0M | -$0.23 |
| Q1 FY2025 | 31 Mar 2025 | $23.4M | -$3.5M | -$0.41 |
| Q4 FY2024 | 31 Dec 2024 | $26.3M | -$1.5M | -$0.18 |
| Q3 FY2024 | 30 Sep 2024 | $21.7M | -$2.9M | -$0.34 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Soft Tissue Repair Products | $91.3M | 88.6% |
| Bone Fusion Products | $11.8M | 11.4% |
Company events
The newest 8-K filings of 176 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 29 Oct 2026 | 8-K | Investor update | 7.01 |
| 16 Oct 2026 | 8-K | Other events | 8.01 |
| 1 Oct 2026 | 8-K | Shareholder vote, Other events | 5.07, 8.01 |
| 11 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 11 Aug 2026 | 8-K/A | Material agreement, Investor update | 1.01, 7.01, 9.01 |
| 29 Jul 2026 | 8-K | Material agreement, Investor update | 1.01, 7.01, 9.01 |
| 9 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 4 Jun 2026 | 8-K | Agreement ended | 1.02 |
| 11 May 2026 | 8-K | Results | 2.02, 9.01 |
| 24 Mar 2026 | 8-K | Results | 2.02, 9.01 |
| 2 Mar 2026 | 8-K | Investor update | 7.01, 9.01 |
| 23 Jan 2026 | 8-K | Results | 2.02, 9.01 |
Every filing
The newest filings with the SEC of 491 held.
| Filed | Form | Period |
|---|---|---|
| 29 Oct 2026 | 8-K | 29 Oct 2026 |
| 28 Oct 2026 | 425 | – |
| 16 Oct 2026 | 425 | – |
| 16 Oct 2026 | 8-K | 15 Oct 2026 |
| 16 Oct 2026 | 425 | – |
| 1 Oct 2026 | 8-K | 30 Sep 2026 |
| 4 Sep 2026 | DEFM14A | – |
| 20 Aug 2026 | 425 | – |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 11 Aug 2026 | 425 | – |
| 11 Aug 2026 | 425 | – |
| 11 Aug 2026 | 8-K | 11 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 31 Jul 2026 | Tall Pines Capital, LLC | 13G amended | 0% | 0 |
| 14 Apr 2026 | BAIRD TRUST Co | 13G amended | 0% | 21.1K |
| 6 Feb 2026 | BAIRD TRUST Co | 13G | 8.5% | 760.3K |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 374.8K | +5.72% | 1.79 |
| 30 Sep 2026 | 354.5K | +14.36% | 2.79 |
| 15 Sep 2026 | 310.0K | +10.56% | 1.09 |
| 31 Aug 2026 | 280.4K | +32.82% | 1 |
| 14 Aug 2026 | 211.1K | -2.3% | 1 |
| 31 Jul 2026 | 216.1K | -42.76% | 1 |
| 15 Jul 2026 | 377.5K | +4.41% | 7.22 |
| 30 Jun 2026 | 361.6K | +24.57% | 4.59 |
Funds that hold it
From each fund's latest Form 13F.
78 funds held it at 30 Jun 2026: 46 added and 15 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 248,827 | $5.9M | +20,060 |
| Vanguard Capital Management LLC | 194,897 | $4.6M | +43,530 |
| Royal Bank of Canada | 130,995 | $3.1M | -394 |
| Stonebridge Wealth Management, LLC | 129,452 | $3.1M | -7,447 |
| AQR Capital Management LLC | 112,207 | $2.6M | +72,269 |
| Geode Capital Management, LLC | 89,179 | $2.1M | +3,517 |
| Goldman Sachs Group Inc. | 74,198 | $1.8M | +52,613 |
| Renaissance Technologies LLC | 67,400 | $1.6M | +2,720 |
| State Street Corp. | 63,469 | $1.5M | +780 |
| Squarepoint Ops LLC | 53,811 | $1.3M | -19,796 |
Peers
Companies in the same industry.
- Intuitive Surgical Inc. (ISRG): revenue $11.6B, market value $149.8B
- Edwards Lifesciences Corp. (EW): revenue $6.5B, market value $53.1B
- Steris plc (STE): revenue $6.0B, market value $22.1B
- Zimmer Biomet Holdings, Inc. (ZBH): revenue $8.5B, market value $18.0B
- Smith & Nephew plc (SNN): revenue $6.2B, market value $13.0B
- Align Technology Inc. (ALGN): revenue $4.1B, market value $10.7B
- MSA Safety Inc. (MSA): revenue $1.9B, market value $6.9B
- Establishment Labs Holdings Inc. (ESTA): revenue $245.8M, market value $1.9B
- Cadre Holdings, Inc. (CDRE): revenue $685.6M, market value $1.3B
- Enovis Corp. (ENOV): revenue $2.3B, market value $1.1B